According to the current analysis of Emergen Research, the global Active Psoriatic Arthritis Market was valued at USD 7.15 billion in 2019 and is expected to reach USD 13.64 billion by 2027, at a CAGR of 9.2%. Significant growth in incidences of active psoriatic arthritis is observed across emerging countries together with increasing elderly population. Also, poor standard of living due to stressful work-life balance resulting in the overstimulation of immune system. Rising advancements in biosimilars and robust pipeline of biologic products are expressively enhancing the availability of safe and efficient psoriatic arthritis treatment. High incidence of psoriatic arthritis is extensively experienced by those patients who are already suffering from plague psoriasis. These scenarios are actively contribute to the industry growth of active psoriatic arthritis treatment and therefore, demand for drugs linked with this treatment are also likely to escalate in the forecast period.

Take a Break and Get a sample of the report: https://www.emergenresearch.com/request-sample/72

Active psoriatic arthritis and rheumatoid arthritis showcase more or less similar signs and symptoms of swollen joints and are unbearably painful and warm to touch. Consequently, possibilities of misdiagnosis are unfavorably high and is most likely to challenge the growth scenarios of the industry in the forecast period. Factors likely to restrict the industry growth include high cost associated with treatments and target drugs along with stringent government rules and regulations. Moreover, research across the world suggests that patients suffering from active psoriatic arthritis are recorded to be significantly vulnerable to the ongoing COVID‐19 pandemic. Moreover, incapability to access required healthcare services and increasing burden of excessive stress is causing exacerbations in patients suffering from active psoriatic arthritis.

Global Active Psoriatic Arthritis Market COVID-19 Analysis

The report offers an extensive analysis of the factors that are likely to influence the growth of the industry. The research study considers the COVID-19 pandemic a key growth influencing factor. The pandemic has negatively impacted the Active Psoriatic Arthritis industry through disruptions in global supply chains and grueling economic conditions. The report extensively analyzes the impact of the pandemic on the Active Psoriatic Arthritis market on a global as well as regional scale. To be updated, the report is furnished with the latest impact of the currently unfolding coronavirus pandemic on the Active Psoriatic Arthritis industry. The pandemic began in late 2019 and hit the world in early 2020, disrupting the normal lives and affecting every segment of the world. The report covers the impact of the pandemic on the Active Psoriatic Arthritis market and its key segment. The report also offers an initial and future assessment of the impact of the pandemic on the Active Psoriatic Arthritis market and offers revenue estimations in a post-COVID-19 scenario.

Revenue and cost profit analysis of major player dominating the Active Psoriatic Arthritis market

The report also takes into consideration the effect of the different restrictions imposed in different regions on the Active Psoriatic Arthritis industry and its key segments. It also offers a current and future impact analysis of the pandemic on the overall Active Psoriatic Arthritis market.

Emerging countries of Asia Pacific offer large number of patient pool as countries like India and China holds high population density along with high frequency of psoriatic arthritis especially in geriatric population. Asia Pacific registered noteworthy CAGR of 10.2% in 2019 and is expected to intensify its growth rate over the forecast period

Frequencies of active psoriatic arthritis symptoms are extensively high in those patients already suffering from psoriasis. The most widespread autoimmune disease in the United States is psoriasis affecting more than 7.5 to 8 million people every year.

Key market players profiled for this industry analysis include Novartis International AG, Johnson & Johnson Services, AbbVie, AstraZeneca, Amgen, Celgene Corporation, Bristol-Myers Squibb Company, Bausch Health Companies, Eli Lilly and Company and Pfizer among other companies

Any information regarding report, Visit Here: https://www.emergenresearch.com/purchase-enquiry/72

The segmentation of the market is done on the basis of product types, application spectrum, and the key regions of the Active Psoriatic Arthritis market. Along with this, the report also provides extensive coverage of the key companies and their strategic schemes to gain a substantial market position.

Product Outlook (Revenue in Million USD; 2017–2027)

  • Prescriptions
  • OTC
  • Other

Drug Class Outlook (Revenue in Million USD; 2017–2027)

  • Biologics
  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
  • Non-Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs)
  • Other

By Route of Administration (Revenue in Million USD; 2017–2027)

  • Injectable
  • Oral
  • Topical

The report offers a comprehensive overview of the global Active Psoriatic Arthritis market scenario pertaining to market value, volume, production and consumption rates, and market segmentation based on types, regions, and applications.

To identify the key trends in the industry, click on the link below:  https://www.emergenresearch.com/industry-report/active-psoriatic-arthritis-market 

North America dominated the market with largest market revenue share of 37.1% in 2019 and is closely followed by the European region in terms of revenue share primarily owing to rising prevalence of target disease, substantial investment opportunities, favorable reimbursement scenarios, and due to high accessibility of advanced products.

Regional Outlook (Revenue in Million USD; 2017–2027)

  • North America
    • S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of the Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Middle East & Africa
  • Latin America
    • Brazil

Request customization of the report: https://www.emergenresearch.com/request-for-customization/72

Key Questions Addressed in the Report:

  • Who are the leading players of the Active Psoriatic Arthritis industry?
  • Which region is expected to dominate the market in the coming years?
  • What are the key applications of the Active Psoriatic Arthritis market?
  • Which segment is expected to garner traction during the coming years?
  1. Report Overview

1.1 Research Scope

1.2 Key Active Psoriatic Arthritis market segments

1.3 Target players

1.4 Market analysis by type

1.5 Market analysis by application

1.6 Key learning objectives

1.7 Report timeline

  1. Global Growth Trends

2.1 Global Active Psoriatic Arthritis market size

2.2 Latest trends of the Active Psoriatic Arthritis market by region

2.3 Key corporate trends

About Us:

At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: [email protected]

Facebook | LinkdIn | Twitter | Blogs

Leave a comment

Your email address will not be published. Required fields are marked *